CCA
AGTC

Clearwater Capital Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Clearwater Capital Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7
Closed – – 584
2018
Q1 		$0 Buy
+7
New +$29 ﹤0.01% 630

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Clearwater Capital Advisors's AGTC Position: Q2 2018 in Review

Clearwater Capital Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2018, closing a stake of 7 shares.

Clearwater Capital Advisors first reported a position in AGTC in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 64 funds tracked by Wall St. Rank hold AGTC as of Q2 2018.

  • Clearwater Capital Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q2 2018 after selling out during the quarter.
  • Clearwater Capital Advisors sold 7 Applied Genetic Technologies Corporation shares in Q2 2018.
  • Clearwater Capital Advisors first reported a position in Applied Genetic Technologies Corporation in Q1 2018 and held it in 1 quarter.
  • Clearwater Capital Advisors's Applied Genetic Technologies Corporation position peaked at $0 in Q1 2018.
  • 64 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2018.

Based on Clearwater Capital Advisors's 13F filing for Q2 2018, filed 16 Aug 2018.